Sec. 205. Increasing education and awareness of treatments for opioid use disorders
287 words·~1 min read·
/bill/113/s/689/is/section-205A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
In order to improve the quality of care delivery and treatment outcomes among patients with opioid use disorders, the Secretary of Health and Human Services (referred to in this section as the Secretary ), acting through the Administrator for the Substance Abuse and Mental Health Services Administration, may advance, through existing programs as appropriate, the education and awareness of providers, patients, and other appropriate stakeholders regarding all products approved by the Food and Drug Administration to treat opioid use disorders. The activities described in subsection
(a)may include— disseminating evidence-based practices for the treatment of opioid use disorders; facilitating continuing education programs for health professionals involved in treating opioid use disorders; increasing awareness among relevant stakeholders of the treatment of opioid use disorders; assessing current barriers to the treatment of opioid use disorders for patients and providers and development and implementation of strategies to mitigate such barriers; and continuing innovative approaches to the treatment of opioid use disorders in various treatment settings, such as prisons, community mental health centers, primary care, and hospitals. Not later than 1 year after the date of enactment of this Act, if the Secretary carries out the activities under this section, the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report that examines— the activities the Substance Abuse and Mental Health Services Administration conducts under this section, including any potential impacts on health care costs associated with such activities; the role of adherence in the treatment of opioid use disorders and methods to reduce opioid use disorders; and recommendations on priorities and strategies to address co-occurring substance use disorders and mental illnesses.